Montelukast, Levocetirizine Dihydrochloride and Ambroxol Hydrochloride Tablet

Description

Alevac-AM is a triple-action combination medicine consisting of Montelukast + Levocetirizine Dihydrochloride + Ambroxol Hydrochloride offered by Pharvax Biosciences. This combination medicine is used to treat Allergic conditions 

It is nowadays getting popular among the doctors for the treatment of chronic allergic conditions like Allergic Rhinitis, Asthma and Chest Congestion. 

Montelukast, Levocetirizine Dihydrochloride and Ambroxol HCl Tablet is now available for PCD pharma franchise, monopoly marketing and distribution.

What is Alevac-AM?

Alevac-AM is a unique one tablet blend of three actives: Montelukast, a leukotriene receptor antagonist, which prevents inflammation and constriction of the airway.  Levocetirizine Dihydrochloride, a third-generation anti-histamine that has a profound effect on allergic symptoms such as sneezing, itching and rhinorrhoea; and Ambroxol Hydrochloride, a mucolytic that reduces mucus viscosity, increasing mucus clearance.

Key Therapeutic Uses

• Allergic rhinitis with associated nasal congestion and mucus production
• Bronchial asthma, especially with allergic triggers
• Chronic cough with excessive mucus/phlegm production
• Seasonal and perennial allergies accompanied by chest congestion
• Allergic bronchitis and related upper and lower respiratory tract symptoms
• Combined allergic and productive cough conditions where a single antihistamine or mucolytic is insufficient

Mechanism of Action

Montelukast specifically inhibits the cysteinyl leukotriene receptor type one (CysLT1), stopping leukotriene-driven airway swelling, narrowing, and excess mucus release. Levocetirizine, being the active form of cetirizine, targets peripheral H1-histamine receptors to offer quick and lasting help against sneezing, itchiness, tearing, and a runny nose, causing little drowsiness. Ambroxol acts as a mucokinetic drug by splitting mucus sugar fibre structures and boosting lung surfactant creation, aiding better mucus removal and breathing ease. Together, these three parts make Alevac-AM useful for people showing mixed allergy-breathing symptom groups.

Dosage and Administration

Montelukast, Levocetirizine Dihydrochloride and Ambroxol HCl Tablet needs strict adherence to instructions from a licensed doctor, usually one time per day, best at night, eaten with meals or on an empty stomach. Dosing amounts and how long you take it rely on age level, severity of signs, and reaction to care. Patients must not change the amount or stop the drug without asking a doctor, even when the signs get better before finishing the set time.

Safety Information and Precautions

Montelukast, Levocetirizine Dihydrochloride and Ambroxol HCl Tablet should be used with caution in patients with hepatic impairment, a history of neuropsychiatric reactions to montelukast, or hypersensitivity to any of its components. Mild drowsiness may occur in some patients due to the antihistamine component, so caution is advised while driving or performing tasks requiring mental alertness. The tablet should be avoided in pregnant or breastfeeding women unless specifically advised by a physician. Patients with known hypersensitivity to leukotriene antagonists, antihistamines, or mucolytics should not use this product. As with any combination therapy, regular medical follow-up is recommended, especially for long-term use.

Note: The above content is only for information purposes and does not claim anything. Therefore, always seek advice from your doctor before taking this medication.

Why Choose Alevac-AM from Pharvax Biosciences?

• Manufactured under strict WHO-GMP quality standards 
• Unique triple-combination formula addressing allergy, inflammation, and mucus together
• Consistent potency and stability across batches
• Strong physician acceptance in the respiratory and ENT segments
• Comprehensive franchise support, including visual aids, product samples, and rate lists
• Monopoly-based PCD pharma franchise rights available pan-India

Alevac-AM PCD Pharma Franchise Opportunity

Pharvax Biosciences is expanding its respiratory and anti-allergic tablet range through PCD pharma franchise tie-ups across India. Partners associating for Alevac-AM benefit from a fast-moving, doctor-preferred combination brand, complete with low-investment entry, attractive margins, monopoly rights, and continuous business support.

Montelukast, Levocetirizine Dihydrochloride and Ambroxol Hydrochloride Tablet PCD Pharma Franchise

Looking for a Montelukast, Levocetirizine Dihydrochloride and Ambroxol Hydrochloride Tablet PCD Pharma Franchise with genuine monopoly rights and reliable supply? Pharvax Biosciences offers Montelukast, Levocetirizine Dihydrochloride and Ambroxol Hydrochloride Tablet PCD Pharma Franchise program, supporting partners in building a profitable respiratory and anti-allergic product range.